Alexandria T. Phan

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

Martyn Caplin, Marianne Pavel, Jarosław B. Ćwikła et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text

Medicine, Endocrinology, Oncology +17

Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study

James C. Yao, Alexandria T. Phan, David Z. Chang et al. · Journal of Clinical Oncology · 2008 · 646 citations · Full text

Medicine, Endocrinology, Oncology +16

Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors

Pamela L. Kunz, Diane Reidy‐Lagunes, Lowell Anthony et al. · Pancreas · 2013 · 586 citations · Full text

Medicine, Endocrinology, Oncology +13

Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators

Montserrat Ayala‐Ramirez, Lei Feng, Marcella M. Johnson et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 427 citations · Full text

Medicine, Oncology, Surgery +13

Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b

James C. Yao, Alexandria T. Phan, Paulo M. Hoff et al. · Journal of Clinical Oncology · 2008 · 411 citations · Full text

Medicine, Oncology, Pharmacology +17